🇺🇸 FDA
Patent

US 7858786

Pyrimidines and pyrazines useful as modulators of ion channels

granted A61PA61P1/04A61P19/02

Quick answer

US patent 7858786 (Pyrimidines and pyrazines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P19/02, A61P25/00, A61P25/02